These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21397212)

  • 1. The molecular genetics of executive function: role of monoamine system genes.
    Barnes JJ; Dean AJ; Nandam LS; O'Connell RG; Bellgrove MA
    Biol Psychiatry; 2011 Jun; 69(12):e127-43. PubMed ID: 21397212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of attention.
    Bellgrove MA; Mattingley JB
    Ann N Y Acad Sci; 2008; 1129():200-12. PubMed ID: 18591481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene.
    Reuter M; Ott U; Vaitl D; Hennig J
    J Cogn Neurosci; 2007 Mar; 19(3):401-8. PubMed ID: 17335389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intellectual deficits in children with ADHD beyond central executive and non-executive functions.
    Tillman CM; Bohlin G; Sørensen L; Lundervold AJ
    Arch Clin Neuropsychol; 2009 Dec; 24(8):769-82. PubMed ID: 19825866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD).
    Toplak ME; Bucciarelli SM; Jain U; Tannock R
    Child Neuropsychol; 2009 Jan; 15(1):53-72. PubMed ID: 18608232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD.
    Braet W; Johnson KA; Tobin CT; Acheson R; McDonnell C; Hawi Z; Barry E; Mulligan A; Gill M; Bellgrove MA; Robertson IH; Garavan H
    Neuropsychologia; 2011 Jun; 49(7):1641-50. PubMed ID: 21232548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.
    Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP
    Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the genetics of executive function.
    Greene CM; Braet W; Johnson KA; Bellgrove MA
    Biol Psychol; 2008 Sep; 79(1):30-42. PubMed ID: 18178303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A developmental perspective on the measurement of cognitive deficits in attention-deficit/hyperactivity disorder.
    Kipp K
    Biol Psychiatry; 2005 Jun; 57(11):1256-60. PubMed ID: 15949996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurocognitive function in child and adolescent psychopathology].
    Chamorro Oschilewsky R
    Vertex; 2011; 22(96):119-24. PubMed ID: 21977606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter genotype predicts behavioural and neural measures of response inhibition.
    Cummins TD; Hawi Z; Hocking J; Strudwick M; Hester R; Garavan H; Wagner J; Chambers CD; Bellgrove MA
    Mol Psychiatry; 2012 Nov; 17(11):1086-92. PubMed ID: 21876545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of attention-deficit/hyperactivity disorder.
    Faraone SV; Perlis RH; Doyle AE; Smoller JW; Goralnick JJ; Holmgren MA; Sklar P
    Biol Psychiatry; 2005 Jun; 57(11):1313-23. PubMed ID: 15950004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of serotonin and effort in voluntary attention: evidence of genetic variation in N1 modulation.
    Enge S; Fleischhauer M; Lesch KP; Strobel A
    Behav Brain Res; 2011 Jan; 216(1):122-8. PubMed ID: 20655956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Reelin (RELN) gene is associated with executive function in healthy individuals.
    Baune BT; Konrad C; Suslow T; Domschke K; Birosova E; Sehlmeyer C; Beste C
    Neurobiol Learn Mem; 2010 Nov; 94(4):446-51. PubMed ID: 20727978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals.
    Vakalopoulos C
    Med Hypotheses; 2007; 68(1):210-21. PubMed ID: 16997497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive function profile of children with attention deficit hyperactivity disorder.
    Shallice T; Marzocchi GM; Coser S; Del Savio M; Meuter RF; Rumiati RI
    Dev Neuropsychol; 2002; 21(1):43-71. PubMed ID: 12058835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic and dopaminergic modulation of attentional processes.
    Boulougouris V; Tsaltas E
    Prog Brain Res; 2008; 172():517-42. PubMed ID: 18772049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained attention and age predict inhibitory control during early childhood.
    Reck SG; Hund AM
    J Exp Child Psychol; 2011 Mar; 108(3):504-12. PubMed ID: 20801457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.